Nitrosative stress plays an important role in wnt pathway activation in diabetic retinopathy

Antioxidants and Redox Signaling

Volumn 18, Issue 10, 2013, Pages 1141-1153

  Liu, Qiuping ^a,b   Li, Jingming ^a,b   Cheng, Rui ^b   Chen, Ying ^b   Lee, Kyungwon ^b   Hu, Yang ^b   Yi, Jinglin ^a   Liu, Zuguo ^c   Ma, Jian Xing ^b,c  

^a NANCHANG UNIVERSITY   (China)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; BETA CATENIN; DICHLOROFLUORESCEIN; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LUCIFERASE; PEROXYNITRITE; STREPTOZOCIN; TETRAKIS(4 SULFOPHENYL)PORPHINE; URIC ACID; VASCULOTROPIN; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANONICAL ANALYSIS; CATALYST; CELL INFILTRATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; NITROSATIVE STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; RETINA CELL; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ALDEHYDES; ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; PEROXYNITROUS ACID; SIGNAL TRANSDUCTION; URIC ACID; WNT SIGNALING PATHWAY;

EID: 84874070358     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4583     Document Type: Article

References (50)

1. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287: 2563-2569, 2002.
2. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, 3rd, and Klein R. Diabetic retinopathy. Diabetes Care 21: 143-156, 1998.
3. Behar-Cohen FF, Heydolph S, Faure V, Droy-Lefaix MT, Courtois Y, and Goureau O. Peroxynitrite cytotoxicity on bovine retinal pigmented epithelial cells in culture. Biochem Biophys Res Commun 226: 842-849, 1996.
4. Bienz M and Clevers H. Linking colorectal cancer to Wnt signaling. Cell 103: 311-320, 2000.
5. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54: 1-7, 2005.
6. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, and Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44: 834-838, 2001.
7. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, and Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51: 1076-1082, 2002.
8. Chen Y, Hu Y, Zhou T, Zhou KK, Mott R, Wu M, Boulton M, Lyons TJ, Gao G, and Ma JX. Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol 175: 2676-2685, 2009.
9. Chen Y, Moiseyev G, Takahashi Y, and Ma JX. RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-/-mice. Invest Ophthalmol Vis Sci 47: 1177-1184, 2006.
10. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480, 2006.
11. Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, and Geller DA. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res 69: 3764-3771, 2009.
12. Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, and Fantl WJ. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 63: 3145-3153, 2003.
13. El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, and Caldwell RB. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 162: 1995-2004, 2003.
14. Hackam AS. The Wnt signaling pathway in retinal degenerations. IUBMB Life 57: 381-388, 2005.
15. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411: 157-160, 1997.
16. He X, Semenov M, Tamai K, and Zeng X. LDL receptorrelated proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131: 1663-1677, 2004.
17. Kiss L and Szabo C. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite- mediated cytotoxicity. Mem Inst Oswaldo Cruz 100 Suppl 1: 29-37, 2005.
18. Lamalice L, Le Boeuf F, and Huot J. Endothelial cell migration during angiogenesis. Circ Res 100: 782-794, 2007.
19. Lee K, Hu Y, Ding L, Chen Y, Takahashi Y, Mott R, and Ma JX. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy. Diabetes 2012. DOI 10.2337/db11-0300.
20. Logan CY and Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004.
21. Luo Q, Kang Q, Si W, JiangW, Park JK, Peng Y, Li X, LuuHH, Luo J, Montag AG, Haydon RC, and He TC. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 55958-55968, 2004.
22. Maiese K, Li F, Chong ZZ, and Shang YC. The Wnt signaling pathway: aging gracefully as a protectionist? Pharmacol Ther 118: 58-81, 2008.
23. Masckauchan TN and Kitajewski J. Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology (Bethesda) 21: 181-188, 2006.
24. Miller JW. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol 151: 13-23, 1997.
25. Miller JW, Adamis AP, and Aiello LP. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev 13: 37-50, 1997.
26. Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, and Inomata H. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 27: 48-52, 1995.
27. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
28. Pacher P, Obrosova IG, Mabley JG, and Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 12: 267-275, 2005.
29. Pacher P and Szabo C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol 6: 136-141, 2006.
30. Park K, Lee K, Zhang B, Zhou T, He X, Gao G, Murray AR, and Ma JX. Identification of a novel inhibitor of the canonical Wnt pathway. Mol Cell Biol 31: 3038-3051, 2011.
31. Powers SK and Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 88: 1243-1276, 2008.
32. Samarzija I, Sini P, Schlange T, Macdonald G, and Hynes NE. Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways. Biochem Biophys Res Commun 386: 449-454, 2009.
33. Schaur RJ. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 24: 149-159, 2003.
34. Sharma R, Sharma A, Dwivedi S, Zimniak P, Awasthi S, and Awasthi YC. 4-Hydroxynonenal self-limits fas-mediated DISC-independent apoptosis by promoting export of Daxx from the nucleus to the cytosol and its binding to Fas. Biochemistry 47: 143-156, 2008.
35. Takeda M, Mori F, Yoshida A, Takamiya A, Nakagomi S, Sato E, and Kiyama H. Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats. Diabetologia 44: 1043-1050, 2001.
36. Tang J and Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res 30: 343-358, 2011.
37. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42: 318-343, 2003.
38. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007.
39. Wodarz A and Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59-88, 1998.
40. Yang Y, Sharma R, Sharma A, Awasthi S, and Awasthi YC. Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol 50: 319-336, 2003.
41. Yokoyama T, Yamane K, Minamoto A, Tsukamoto H, Yamashita H, Izumi S, Hoppe G, Sears JE, and Mishima HK. High glucose concentration induces elevated expression of anti-oxidant and proteolytic enzymes in cultured human retinal pigment epithelial cells. Exp Eye Res 83: 602-609, 2006.
42. Zarkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24: 281-291, 2003.
43. Zhang B, Zhou KK, and Ma JX. Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. Diabetes 59: 1809-1816, 2010.
44. Zhang SX, Ma JX, Sima J, Chen Y, Hu MS, Ottlecz A, and Lambrou GN. Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygeninduced retinopathy. Am J Pathol 166: 313-321, 2005.
45. Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, and Caldwell RB. Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res 2: 96-103, 2011.
46. Zhang W, Liu H, Rojas M, Caldwell RW, and Caldwell RB. Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy 3: 609-628, 2011.
47. Zhang X, Gaspard JP, and Chung DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 61: 6050-6054, 2001.
48. Zheng L and Kern TS. Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci 14: 3974-3987, 2009.
49. Zhou T, Hu Y, Chen Y, Zhou KK, Zhang B, Gao G, and Ma JX. The pathogenic role of the canonical Wnt pathway in age-related macular degeneration. Invest Ophthalmol Vis Sci 51: 4371-4379, 2010.
50. Zhou T, Zhou KK, Lee K, Gao G, Lyons TJ, Kowluru R, and Ma JX. The role of lipid peroxidation products and oxidative stress in activation of the canonical wingless-type MMTV integration site (WNT) pathway in a rat model of diabetic retinopathy. Diabetologia 54: 459-468, 2011.